Hong Kong Stock Market's concept of innovative medicine rises, BeiGene surges more than 7%

Hong Kong stocks innovative pharmaceutical concept upswing, BeiGene rose over 7%, Hutchison China MediTech, SinoMab BioScience, and Kangmei Pharmaceutical followed suit.